无导线起搏器研究进展  

Research progress of leadless pacemaker

作　　者：禹子清 宿燕岗 YU Ziqing;SU Yangang(Department of Cardiology,Zhongshan Hospital Affiliated to Fudan University,Shanghai 200032,China)

机构地区：[1]复旦大学附属中山医院心内科,上海200032

出　　处：《实用心电学杂志》2023年第4期254-260,共7页Journal of Practical Electrocardiology

基　　金：上海市科学技术委员会资助项目(201409004200)。

摘　　要：近年来兴起的无导线起搏器(leadless pacemaker,LPM)避免了传统有导线起搏器的导线和囊袋相关并发症,如三尖瓣反流、电极导线断裂、电极导线心内膜炎或囊袋感染。LPM不仅在安全性上较传统起搏器有显著优势,而且起搏相关参数的稳定性也在相对较长的随访时间内得到证实。目前,LPM已在我国获批上市,虽然其应用目前尚处在初级阶段,但植入量迅速增长,因此可预见到未来发展前景良好。本文将围绕现有LPM的临床应用证据、LPM植入相关技术及术后管理、未来LPM的发展方向等内容进行综述。Leadless pacemakers(LPMs),which have emerged in recent years,avoid the lead-and pocketrelated complications associated with conventional lead pacemakers,such as tricuspid regurgitation,lead fracture,lead endocarditis or pocket infection.Not only has LPM a significant advantage over conventional pacemakers in terms of safety,but also its stability of pacing-related parameters has been demonstrated during a relatively long follow-up period.At present,LPM has been approved for marketing in China.Although the application of LPM is still in its infancy,the implantation volume is growing rapidly,therefore its development prospect in the future is good.This article reviews the clinical application evidences of existing LPM,related techniques and postoperative management of LPM implantation,future development direction of LPM,and so on.

关 键 词：无导线起搏器 并发症 导线 三尖瓣反流 囊袋感染 

分 类 号：R541.7[医药卫生—心血管疾病]